Lupus Research Alliance and Lupus Therapeutics Response to Positive Data from Phase 2 Study on Potential First-in-class Lupus Treatment
New York, NY, June 1, 2022 — The Lupus Research Alliance (LRA) and its clinical trial arm Lupus Therapeutics congratulate Bristol...